Ignite Creation Date:
2025-12-26 @ 11:13 AM
Ignite Modification Date:
2026-03-07 @ 1:48 PM
Study NCT ID:
NCT03392428
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2017-12-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer
Sponsor:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ANZUP 1603
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None